ANAPTYSBIO INC. - COMMON STOCK
20,75
13-ноября-24 16:45:00
15 мин. задержка
Акции
-0,75
-3,49%
Сегодняшний диапазон
20,55 - 21,89
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Anaptys Announces Third Quarter 2024 Financial Results and Provides Business Update
05 ноя 2024 16:15:00 Источник Nasdaq GlobeNewswire
-
Anaptys Announces Participation in November and December Investor Conferences
05 ноя 2024 16:15:00 Источник Nasdaq GlobeNewswire
-
Anaptys Announces Participation in September Investor Conferences
29 авг 2024 09:15:00 Источник Nasdaq GlobeNewswire
-
Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering
14 авг 2024 05:00:00 Источник Nasdaq GlobeNewswire
-
Anaptys Announces Second Quarter 2024 Financial Results and Provides Business Update
05 авг 2024 16:15:00 Источник Nasdaq GlobeNewswire
-
Anaptys Announces First Quarter 2024 Financial Results and Provides Business Update
09 май 2024 16:15:00 Источник Nasdaq GlobeNewswire
-
09 май 2024 16:10:00 Источник Nasdaq GlobeNewswire
-
09 май 2024 16:05:01 Источник Nasdaq GlobeNewswire
-
Anaptys Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
11 мар 2024 16:15:00 Источник Nasdaq GlobeNewswire
-
Anaptys to Present at TD Cowen’s 44th Annual Health Care Conference and 2024 AAD Annual Meeting
29 фев 2024 09:15:00 Источник Nasdaq GlobeNewswire
-
Anaptys to Present at Guggenheim’s 6th Annual Biotechnology Conference
31 янв 2024 09:15:00 Источник Nasdaq GlobeNewswire
-
27 ноя 2023 16:15:00 Источник Nasdaq GlobeNewswire
-
Anaptys Named a BioSpace 2024 Best Places to Work Winner
07 ноя 2023 16:15:00 Источник Nasdaq GlobeNewswire
-
Anaptys Announces Third Quarter 2023 Financial Results and Provides Business Update
02 ноя 2023 16:15:00 Источник Nasdaq GlobeNewswire
-
Anaptys Announces Participation in November Investor Conferences
01 ноя 2023 09:15:00 Источник Nasdaq GlobeNewswire
-
Anaptys to Present Phase 1 Data on ANB032, its BTLA Agonist Antibody, at the 32nd EADV Congress
11 окт 2023 09:15:00 Источник Nasdaq GlobeNewswire
-
09 окт 2023 08:15:00 Источник Nasdaq GlobeNewswire
-
09 окт 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
AnaptysBio Announces Appointment of John Orwin as Chairman of the Board of Directors
18 сен 2023 16:15:00 Источник Nasdaq GlobeNewswire
-
AnaptysBio to Present at the Stifel 2023 Immunology and Inflammation Virtual Summit
12 сен 2023 09:15:00 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >